ACE2 and COVID-19: Along with hypertension and diabetes being common comorbidities for COVID-19, older individuals and males are more susceptible to the infection (and have demonstrated more severe cardiopulmonary complications from coronavirus), both of which are associated with differences in ACE2 expression and activity.